Princeton, NJ-Nov. 16, 2017-WIRB-Copernicus Group® (WCG™), a provider of solutions that improve the quality and efficiency of clinical research, announced that it is partnering with Veeva Systems Inc. to improve the speed and accuracy of institutional review board (IRB) document transfer. WCG will build a seamless connection between WCG’s MyConnexus™ IRB document management web portal and Veeva Vault eTMF. By linking Vault eTMF with MyConnexus, IRB documentation can be automatically uploaded into the customer’s Vault eTMF to provide inspection-ready eTMF documents immediately, and reduce the possibility of human error during IRB document transfer. This eliminates the need for clinical trial teams to download documents from the IRB portal only to upload them into their eTMF platform, along with the associated applied metadata. Study documents and associated data are seamlessly transferred from one application to another without human intervention, thereby saving significant time and effort, while increasing the reliability of interactions. “WCG’s goal is to increase the efficiency of the clinical trial process, while maintaining the highest level of human subject protection. Partnering with Veeva will save our clients significant document transfer time and increase the accuracy of the process. This new integration will eliminate any lag time between finalizing an IRB document and uploading it to Veeva Vault eTMF,” said Jill Johnston, President of the WCG Clinical Service Organization. WCG’s MyConnexus portal serves as a command center, streamlining and enhancing the way sponsors, clinical research organizations (CROs), and investigative sites conduct the IRB submission and document management process. MyConnexus provides unprecedented oversight capabilities and 24/7 access so that clients can manage and track their IRB submissions in real time. Veeva Vault is a cloud enterprise content and data management platform and suite of applications for life sciences. Veeva Vault eTMF allows active TMF management, providing real-time inspection readiness, enhanced document visibility, and improved control. “This new partnership with WCG will facilitate the sharing of clinical and regulatory documents between MyConnexus and Vault eTMF, and expedite this element of clinical operations for a large number of sponsors, CROs and sites,” added Jennifer Goldsmith, Senior Vice President of Veeva Vault. About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is a provider of solutions that improve the quality and efficiency of clinical research. The industry's first clinical services organization (CSO), WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protections. For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.